Literature DB >> 12212957

Relaxation of proximal and distal isolated human bronchi by halothane, isoflurane and desflurane.

F J Mercier1, E Naline, M Bardou, O Georges, A Denjean, D Benhamou, C Advenier.   

Abstract

Volatile anaesthetics relax airway smooth muscle in vitro. The amount of relaxation might depend on the type and concentration of volatile anaesthetics, the calibre and precontraction level of the bronchi, and also on the species considered. These effects were investigated on isolated human bronchi. Isometric relaxations produced by halothane, isoflurane and desflurane bubbled on human bronchial rings precontracted with carbachol were recorded and compared with time controls. Volatile anaesthetics induced a concentration-dependent relaxation at 0.66, 1.33 and 2 minimum alveolar concentration (MAC). The relaxation was greater in mildly (carbachol 3x10(-7) M) than in highly (carbachol 2x10(-6) M) precontracted bronchi. Halothane was more potent in relaxing distal as compared to proximal bronchi; this differential effect was less pronounced with isoflurane and not observed with desflurane. While the three volatile anaesthetics induced similar relaxation on proximal bronchi, halothane was significantly more potent than desflurane on distal bronchi, with isoflurane being intermediate. The relaxation induced by 1.33 MAC of halothane, isoflurane and desflurane on moderately precontracted distal bronchi (carbachol 1x10(-6) M) was attenuated by pretreatment with glibenclamide 1x10(-5) M. In conclusion, halothane, isoflurane and desflurane exert direct but differential relaxant effects on human isolated bronchial smooth muscle. This may provide supplemental bronchodilation during anaesthesia. Although adenosine triphosphate-sensitive K+ channels are involved in these relaxant effects, they are unlikely to explain the observed differences between the three volatile anaesthetics.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12212957     DOI: 10.1183/09031936.02.00275702

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  7 in total

1.  Effects of propofol and ketamine on ATP-induced contraction of the rat trachea.

Authors:  Masakazu Yamaguchi; Osamu Shibata; Masataka Saito; Maki Yoshimura; Kenji Nishioka; Tetsuji Makita; Koji Sumikawa
Journal:  J Anesth       Date:  2007-01-30       Impact factor: 2.078

2.  Desflurane induces airway contraction mainly by activating transient receptor potential A1 of sensory C-fibers.

Authors:  Jun-ichi Satoh; Michiaki Yamakage
Journal:  J Anesth       Date:  2009-11-18       Impact factor: 2.078

3.  Severe unilateral bronchospasm due to inadequate anesthetic depth: A case report and review of literature.

Authors:  Rohini Bhat Pai; Harihar V Hegde; V Srikanth; P Raghavendra Rao
Journal:  Saudi J Anaesth       Date:  2012-04

4.  Beclomethasone dipropionate and formoterol fumarate synergistically interact in hyperresponsive medium bronchi and small airways.

Authors:  Luigino Calzetta; Maria Gabriella Matera; Francesco Facciolo; Mario Cazzola; Paola Rogliani
Journal:  Respir Res       Date:  2018-04-12

5.  Effects of neuromuscular blockade reversal on bispectral index and frontal electromyogram during steady-state desflurane anesthesia: a randomized trial.

Authors:  Doyeon Kim; Jin Hee Ahn; Hyunjoo Jung; Ka Young Choi; Ji Seon Jeong
Journal:  Sci Rep       Date:  2019-07-19       Impact factor: 4.379

6.  Beclomethasone dipropionate and sodium cromoglycate protect against airway hyperresponsiveness in a human ex vivo model of cow's milk aspiration.

Authors:  Beatrice Ludovica Ritondo; Paola Rogliani; Francesco Facciolo; Silvia Falco; Aurora Vocale; Luigino Calzetta
Journal:  Curr Res Pharmacol Drug Discov       Date:  2020-12-08

7.  Longer time to extubation after general anesthesia with desflurane in patients with obstructive respiratory dysfunction: a retrospective study.

Authors:  Eriko Takeyama; Mariko Nakajima; Yukiko Nakanishi; Eizo Amano; Hiromi Shibuya
Journal:  JA Clin Rep       Date:  2021-04-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.